Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Mir-200b/200c/429 Subfamily Negatively Regulates Rho/Rock Signaling Pathway to Suppress Hepatocellular Carcinoma Metastasis

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis

Downregulation Of Mir-200a Induces Emt Phenotypes And Csc-Like Signatures Through Targeting The Beta-Catenin Pathway In Hepatic Oval Cells

Mir-192, A Prognostic Indicator, Targets the Slc39a6/Snail Pathway to Reduce Tumor Metastasis in Human Hepatocellular Carcinoma

Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

Microrna-200a Inhibits Cell Growth and Metastasis by Targeting Foxa2 in Hepatocellular Carcinoma

MicroRNA-194 Inhibits Cell Invasion and Migration in Hepatocellular Carcinoma Through PRC1-mediated Inhibition of Wnt/β-catenin Signaling Pathway

Microrna-501-3p Suppresses Metastasis and Progression of Hepatocellular Carcinoma Through Targeting LIN7A.

MicroRNA-199 Suppresses Cell Proliferation, Migration and Invasion by Downregulating RGS17 in Hepatocellular Carcinoma.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis.

Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling